Jubilant Ingrevia Approves 40% Stake Acquisition in Zettaone
Jubilant Ingrevia's board has approved the acquisition of a 40% strategic equity stake in Zettaone via a subsidiary.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.